1. Jemal, A., et al. (2011). Global cancer statistics. CA: A Cancer Journal for Clinicians,
61(2), 69–90.
2. Govindan, R., Page, N., Morgensztern, D., Read, W., Tierney, R., Vlahiotis, A., et al. (2006). Changing epidemiology of small cell lung cancer in the United States over the last 30 years: Analysis of the surveillance, epidemiologic, and end results database. Journal of Clinical Oncology,
24, 4539–4544.
3. Howlader, N., Noone, A. M., Krapcho, M., Garshell, J., Neyman, N., Altekruse, S. F., Kosary, C.L., Yu, M., Ruhl, J., Tatalovich, Z., Cho, H., Mariotto, A., Lewis, D. R., Chen, H. S., Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975–2010, National Cancer Institute. Bethesda, MD,
http://seer.cancer.gov/csr/1975_2010/
, based on November 2012 SEER data submission, posted to the SEER web site, April 2013.
4. Novello, S., & Le Chevalier, T. (2003). Chemotherapy for non-small-cell lung cancer. Part 1: Early-stage disease. Oncology (Williston Park),
17(3), 357–364.
5. Schiller, J. H., Harrington, D., Belani, C. P., Langer, C., Sandler, A., Krook, J., et al. (2002). Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. New England Journal of Medicine,
346, 92–98.